Dataset:18164233 Search Result
Clinical Information
Characteristics of children with HRSV infections while on palivizumab
Patient Visit Age (months) Date of NPA # Doses before NPA Time since last dose (days) Age at birth (weeks) Diagnosis Hospitalization (days) Cult. RT-PCR (type) Amino acid change (F gene)
2 6 6 01-26-2005 4 15 31.6 Bronchiolitis No +(B)
2 7 6 01-31-2005 4 20 31.6 Bronchiolitis No +(B)
10 3 6 02-04-2005 4 24 31.7 Bronchiolitis No + +(A)
22 1 6 03-16-2005 6 8 33.1 URTI No +(A) 410(L/V), 422(C/G), 485(S/F)
29 1 10 04-05-2005 6 28 30.3 Bronchiolitis No + −(A)a –a
38 1 7 04-21-2005 7 8 32.7 Bronchiolitis, AOM No +(B) 272(K/E)
45 3 8 03-11-2005 5 23 25 Croup No + +(B)
52 1 11 04-13-2005 6 28 26.4 URTI No + +(B)
58 4 6 04-19-2005 7 6 32.9 Bronchiolitis No + +(B) 107(A/V)
62 2 3 02-18-2005 4 10 33.4 Bronchiolitis Yes (7) + +(A) 183(N/D)
67 1 7 02-18-2005 4 10 33.7 Bronchiolitis No +(A)
Note: URTI: upper respiratory tract infection; AOM: acute otitis media; NPA: nasopharyngeal aspirate
aGenotype and F sequence determined from viral isolate since RT-PCR on clinical sample was negative.